You are here

patent cliff

Merck is broadening its pipeline as Keytruda’s patent cliff looms

Pharma Voice

Tue, 01/14/25 - 09:53 am

With Jakafi's patent cliff looming, Incyte looks to 2025 launches to bulk up revenue by decade's end

Fierce Pharma

Wed, 10/30/24 - 11:42 am

graft vs host disease

follicular lymphoma

squamous cell anal carcinoma

3 patent expirations in 2024 and how companies are pivoting

Pharma Voice

Wed, 04/17/24 - 11:13 am

J&J focuses on newer meds to offset Stelara patent cliff

BioPharma Dive

Wed, 01/24/24 - 10:52 am

The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023

BioSpace

Wed, 08/23/23 - 11:11 am

Eiger Pharmaceuticals

Biopharma Facing Two Major Crises - A Huge Patent Cliff And Price Controls

Forbes

Mon, 06/26/23 - 10:02 am

Pfizer's Heading for a Patent Cliff

Motley Fool

Tue, 05/30/23 - 09:45 am

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

BioPharma Dive

Tue, 02/21/23 - 11:05 am

Bristol Myers Squibb

In Face of Multiple Patent Cliffs, Novartis' Prostate Cancer Drug Shows Promise

BioSpace

Mon, 12/5/22 - 10:58 am

prostate cancer

clinical trials

AbbVie preps for an onslaught of Humira biosimilars in 2023, with Skyrizi and Rinvoq to fill the gap for now

Endpoints

Sun, 10/30/22 - 04:22 pm

Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence

Fierce Pharma

Thu, 08/4/22 - 12:10 pm

Why Regeneron Investors Shouldn't Fear Its Patent Cliff

Motley Fool

Thu, 05/26/22 - 10:08 am

The patent winter is coming

EP Vantage

Wed, 05/25/22 - 10:41 am

Bristol Myers Squibb

'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff

Endpoints

Fri, 02/4/22 - 11:13 am

Merck’s Davis Looking to Diversify in Preparation for Keytruda Patent Cliff

BioSpace

Wed, 10/6/21 - 11:23 pm

The top 15 blockbuster patent expirations coming this decade

Fierce Pharma

Mon, 07/12/21 - 11:08 am

Will the COVID Vaccine Companies Fall off the Patent Cliff?

Motley Fool

Mon, 05/24/21 - 11:29 pm

This Is Why Humira Isn't AbbVie's Biggest Problem Right Now

Motley Fool

Mon, 05/3/21 - 10:55 am

Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024

Center for Biosimilars

Sat, 06/9/18 - 05:23 pm

Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff

Fierce Pharma

Wed, 08/9/17 - 11:20 am

Bristol-Myers Squibb

Pages